Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The microbiome has become an increasingly important topic in animal health. It is especially pertinent in the search for alternative solutions to antibiotics and a more holistic approach to improving and managing animal health. Animal Pharm analyst Sian Lazell found out more at the recent Animal AgTech Innovation Summit in Amsterdam.
Bulgarian firm Huvepharma has received several combination approvals for its Monovet 90 feed additive in the US.
European authorities have paved the way for Bayer Animal Health's Neptra Otic Solution canine ear drops to be approved.
Kindred Biosciences has gained an EU positive opinion for its Mirataz therapeutic for weight loss management in cats.
Canadian animal health immunobiology firm NovaVive has revealed study data has shown the economic benefits of its immunotherapy for calf scours.
Elanco has received a supplemental approval from the US FDA for its Credelio antiparasitic that adds a preventative indication to the product.
US firm Medterra CBD has received an approval for its line of cannabidiol (CBD) products by the National Animal Supplement Council (NASC).
Australian oncology firm PharmAust is close to securing an R&D tax rebate for its canine cancer-focused trials.
European authorities have refused a variation to the terms of the marketing authorization for Ceva Santé Animale's Velactis.
The US FDA has awarded $500,000 to research projects aimed at targeting and defining durations of use for certain medically important antimicrobial drugs.
Industry body Animal Medicines Australia (AMA) has voiced disapproval of the decision by the country's government to introduce a board to the Australian Pesticides and Veterinary Medicines Authority (APVMA).
The British Veterinary Association (BVA) has advocated for a no-deal Brexit to be "taken off the negotiating table" follow analysis of its potential impact on animal health and welfare.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.